Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-25 @ 1:52 PM
Study NCT ID:
NCT03824392
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2019-01-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis
Sponsor:
aTyr Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-28
First Submit QC Date:
None
Study First Post Date:
2019-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-27
Results First Submit QC Date:
None
Results First Post Date:
2023-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-27
Last Update Post Date:
2023-07-18
Last Update Post Date Type:
ACTUAL